
Panelists answer audience questions on treatment targets, fertility-sparing options, and formulations, and why lifestyle change and therapy pair well.
Two days after its merger announcement, US Oncology, Inc., reported that two class action lawsuits have been filed naming US Oncology and its directors as defendants.





